It’s been in development for five years and has at least a year to go. On the eve of its out-of-town debut, the actor playing Lincoln quit. And the producers still need to raise another $15 million to bring the show to New York. There really is no business like show business. (Part three of a three-part series.)
- SOURCES:
- Christopher Ashley, artistic director of La Jolla Playhouse.
- Debby Buchholz, managing director of La Jolla Playhouse.
- Carmen Cusack, actor.
- Quentin Earl Darrington, actor.
- Joe DiPietro, playwright and lyricist.
- Crystal Monee Hall, composer, singer, actor.
- Ivan Hernandez, actor.
- Michael Rushton, professor of arts administration at Indiana University.
- Jeffrey Seller, Broadway producer.
- Alan Shorr, Broadway producer.
- Daniel Watts, writer, choreographer, actor.
- RESOURCES:
- 3 Summers of Lincoln(2025).
- “Review: Visceral ‘3 Summers of Lincoln’ is thrilling and thought-provoking,” by Pam Kragen (San Diego Union-Tribune, 2025).
- “What’s Wrong with the Theatre is What’s Wrong With Society,” by Michael Rushton (ArtsJournal, 2023).
- “American Theater Is Imploding Before Our Eyes,” by Isaac Butler (New York Times, 2023).
- The Moral Foundations of Public Funding for the Arts, by Michael Rushton (2023).
- EXTRAS:
- “How to Make the Coolest Show on Broadway,” by Freakonomics Radio (2024).
- “You Can Make a Killing, but Not a Living,” by Freakonomics Radio (2024).
458. How to Manage Your Goal Hierarchy
In this special crossover episode, People I (Mostly) Admire host Steve Levitt admits to No Stupid Questions co-host Angela Duckworth that he knows almost nothing about psychology. But once Angela gives Steve a quick tutorial…
457. Is Dialysis a Test Case of Medicare for All?
Kidney failure is such a catastrophic (and expensive) disease that Medicare covers treatment for anyone, regardless of age. Since Medicare reimbursement rates are fairly low, the dialysis industry had to find a way to tweak…
456. How to Fix the Hot Mess of U.S. Healthcare
Medicine has evolved from a calling into an industry, adept at dispensing procedures and pills (and gigantic bills), but less good at actual health. Most reformers call for big, bold action. What happens if, instead,…
Policymaking Is Not a Science (Yet) (Ep. 405 Rebroadcast)
Why do so many promising solutions — in education, medicine, criminal justice, etc. — fail to scale up into great policy? And can a new breed of “implementation scientists” crack the code?
How Does New York City Keep Reinventing Itself? (Bonus)
In a word: networks. Once it embraced information as its main currency, New York was able to climb out of a deep fiscal (and psychic) pit. Will that magic trick still work after Covid? In…
455. Are You Ready for a Fresh Start?
Behavioral scientists have been exploring if — and when — a psychological reset can lead to lasting change. We survey evidence from the London Underground, Major League Baseball, and New Year’s resolutions; we look at…
454. Should Traffic Lights Be Abolished?
Americans are so accustomed to the standard intersection that we rarely consider how dangerous it can be — as well as costly, time-wasting, and polluting. Is it time to embrace the lowly, lovely roundabout?
453. A Rescue Plan for Black America
New York Times columnist Charles Blow argues that white supremacy in America will never fully recede, and that it’s time for Black people to do something radical about it. In The Devil You Know: A…
Am I Boring You? (Ep. 225 Rebroadcast)
Researchers are trying to figure out who gets bored — and why — and what it means for ourselves and the economy. But maybe there’s an upside to boredom?
452. Jeff Immelt Knows He Let You Down
Not so long ago, G.E. was the most valuable company in the world, a conglomerate that included everything from light bulbs and jet engines to financial services and The Apprentice. Now it’s selling off body…